HA
HOOK

HHLR Advisors’s HOOKIPA Pharma HOOK Stock Holding History

HHLR Advisors’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-77,072
Closed -$678K – 65
2023
Q2 		$678K Buy
+77,072
New +$856K 0.01% 57
2021
Q3 		– Sell
-26,937
Closed -$2.47M – 95
2021
Q2 		$2.47M Sell
26,937
-46,620
-63% -$6.22M 0.03% 84
2021
Q1 		$9.89M Sell
73,557
-20,768
-22% -$2.51M 0.1% 64
2020
Q4 		$10.5M Hold
94,325
– – 0.08% 75
2020
Q3 		$8.93M Hold
94,325
– – 0.07% 66
2020
Q2 		$11M Hold
94,325
– – 0.1% 53
2020
Q1 		$7.78M Hold
94,325
– – 0.1% 48
2019
Q4 		$11.5M Hold
94,325
– – 0.14% 41
2019
Q3 		$7.07M Buy
94,325
+65,754
+230% +$4.85M 0.1% 50
2019
Q2 		$1.92M Buy
+28,571
New +$3.03M 0.04% 39

Other funds holding HOOK

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HHLR Advisors's HOOK Position: Q3 2023 in Review

HHLR Advisors sold out of HOOKIPA Pharma (HOOK) in Q3 2023, closing a stake of 77,072 shares — an estimated $678K sold.

HHLR Advisors first reported a position in HOOK in Q2 2019 and held it in 10 quarters. The position peaked at $11.5M in Q4 2019. 44 funds tracked by Wall St. Rank hold HOOK as of Q3 2023.

  • HHLR Advisors reported no remaining HOOKIPA Pharma position as of Q3 2023 after selling out during the quarter.
  • HHLR Advisors sold 77,072 HOOKIPA Pharma shares in Q3 2023, an estimated $678K.
  • HHLR Advisors first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 10 quarters.
  • HHLR Advisors's HOOKIPA Pharma position peaked at $11.5M in Q4 2019.
  • 44 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2023.

Based on HHLR Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.